Engineering precision nanoparticles for drug delivery
Michael J. Mitchell,Margaret M. Billingsley,Rebecca M Haley,Marissa E. Wechsler,Nicholas A. Peppas,Robert Langer +5 more
Reads0
Chats0
TLDR
Advances in nanoparticle design that overcome heterogeneous barriers to delivery are discussed, arguing that intelligent nanoparticles design can improve efficacy in general delivery applications while enabling tailored designs for precision applications, thereby ultimately improving patient outcome overall.Abstract:
In recent years, the development of nanoparticles has expanded into a broad range of clinical applications. Nanoparticles have been developed to overcome the limitations of free therapeutics and navigate biological barriers - systemic, microenvironmental and cellular - that are heterogeneous across patient populations and diseases. Overcoming this patient heterogeneity has also been accomplished through precision therapeutics, in which personalized interventions have enhanced therapeutic efficacy. However, nanoparticle development continues to focus on optimizing delivery platforms with a one-size-fits-all solution. As lipid-based, polymeric and inorganic nanoparticles are engineered in increasingly specified ways, they can begin to be optimized for drug delivery in a more personalized manner, entering the era of precision medicine. In this Review, we discuss advanced nanoparticle designs utilized in both non-personalized and precision applications that could be applied to improve precision therapies. We focus on advances in nanoparticle design that overcome heterogeneous barriers to delivery, arguing that intelligent nanoparticle design can improve efficacy in general delivery applications while enabling tailored designs for precision applications, thereby ultimately improving patient outcome overall.read more
Citations
More filters
Journal ArticleDOI
Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
TL;DR: Liposomes, an early version of LNPs, are a versatile nanomedicine delivery platform for treatment of a variety of diseases, such as antitumor and nucleic acid therapeutics and vaccine delivery systems as mentioned in this paper.
Journal Article
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Daniela Schmid,Chun Gwon Park,Christina A. Hartl,Nikita Subedi,Adam N.R. Cartwright,Regina Bou Puerto,James Maiarana,Gordon J. Freeman,Kai W. Wucherpfennig,Michael S. Goldberg,Yiran Zheng,Darrell J. Irvine +11 more
TL;DR: PD-1-targeting nanoparticles containing a TGFβ inhibitor or a TLR7/8 agonist are used to deliver these payloads to T cells or via T cells to the tumor microenvironment, leading to anti-tumor efficacy in vivo.
64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer
Helen Lee,Anthony F. Shields,Barry A. Siegal,Kathy D. Miller,Ian E. Krop,Cynthia X. Ma,Patricia LoRusso,Pamela N. Munster,Karen Campbell,Daniel F. Gaddy,Shannon C. Leonard,Elena Geretti,Stephanie J. Blocker,Dmitri B. Kirpotin,Victor Moyo,Thomas Wickham,Bart S. Hendriks +16 more
TL;DR: Findings provide important evidence and quantification of the EPR effect in human metastatic tumors and support imaging nanoparticle deposition in tumors as a potential means to identify patients well suited for treatment with therapeutic nanoparticles.
Journal ArticleDOI
Role of nanotechnology behind the success of mRNA vaccines for COVID-19.
Amit Khurana,Prince Allawadhi,Isha Khurana,Sachin Allwadhi,Ralf Weiskirchen,Anil Kumar Banothu,Deepak Chhabra,Kamaldeep Joshi,Kala Kumar Bharani +8 more
TL;DR: The emergency use authorization (EUA) by the US-FDA for two mRNA-based vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) has brought hope of addressing the COVID-19 pandemic which has killed more than two million people globally as mentioned in this paper.
Journal Article
Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems B
TL;DR: It is shown that LNP-siRNA systems can exhibit progressively more bilayer structure as the proportion of bilayer DSPC lipid is increased, suggesting that the core of LNPs can exhibit a continuum of nanostructures depending on the proportions and structural preferences of component lipids.
References
More filters
Journal ArticleDOI
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
TL;DR: The protective barrier properties of mucus secretions, how mucus affects the fate of orally administered nanoparticles, and recent developments in nanoparticles engineered to penetrate the mucus barrier are addressed.
Journal ArticleDOI
Airway mucus function and dysfunction.
John V. Fahy,Burton F. Dickey +1 more
TL;DR: Pulmonary defense against environmental injury depends on airway mucus, which traps inhaled toxins that are then cleared from the lungs by ciliary beating and cough.
Journal ArticleDOI
Barrier properties of mucus.
TL;DR: The physiological and biochemical properties that form the mucus barrier are reviewed, including shear-thinning, which makes it an excellent lubricant that ensures an unstirred layer of mucus remains adherent to the epithelial surface.
Journal ArticleDOI
Nanoparticle biointerfacing by platelet membrane cloaking
Che Ming Jack Hu,Ronnie H. Fang,Kuei Chun Wang,Brian T. Luk,Soracha Thamphiwatana,Diana Dehaini,Phu Nguyen,Pavimol Angsantikul,Cindy Wen,Ashley V. Kroll,Cody W. Carpenter,Manikantan Ramesh,Vivian Qu,Sherrina Patel,Jie Zhu,William Shi,Florence M. Hofman,Thomas C. Chen,Weiwei Gao,Kang Zhang,Shu Chien,Liangfang Zhang +21 more
TL;DR: The multifaceted biointerfacing enabled by the platelet membrane cloaking method provides a new approach in developing functional nanoparticles for disease-targeted delivery.
Journal ArticleDOI
The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction.
TL;DR: The effects of nanoparticle size on cellular interaction and in vivo pharmacokinetics, including cellular uptake, biodistribution and circulation half-life of nanoparticles are reviewed.
Related Papers (5)
Nano based drug delivery systems: recent developments and future prospects
Jayanta Kumar Patra,Gitishree Das,Leonardo Fernandes Fraceto,Leonardo Fernandes Fraceto,Estefania Vangelie Ramos Campos,Estefania Vangelie Ramos Campos,Maria del Pilar Rodriguez-Torres,Laura Susana Acosta-Torres,Luis A. Diaz-Torres,Renato Grillo,Mallappa Kumara Swamy,Shivesh Sharma,Solomon Habtemariam,Han-Seung Shin +13 more